Clinical trial
Descriptive Observational Study on the Characteristics of Advanced and Metastatic Melanoma in Spain
NCT03605771 is registered in ClinicalTrials.gov with Grupo Español Multidisciplinar de Melanoma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Descriptive Observational Study on the Characteristics of Advanced and Metastatic Melanoma in Spain
- Lead sponsor
- Grupo Español Multidisciplinar de Melanoma
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- August 7, 2018
- Completion date
- December 31, 2027
- Enrollment
- 400 (estimated)
- Sites
- 39
Conditions
As the registry lists them; a condition with its own page is linked.
advanced cancer, melanoma stage iii, melanoma stage iv